Evaluation Of Bone Mineral Density Among Patients With Depression In Penang Island, Malaysia by Kurmanji, Jaafer Mosadek
EVALUATION OF BONE MINERAL DENSITY AMONG 
PATIENTS WITH DEPRESSION IN PENANG ISLAND, 
MALAYSIA 
 
 
 
 
 
By 
 
 
JAAFER MOSADEK KURMANJI 
 
 
 
 
 
Thesis submitted in fulfillment of the  
requirements for the degree of 
Master of Science 
December 2009 
 
ii 
 
 
 
 
 
 
 
 
Dedication 
This research work is dedicated to my country, 
my father, my mother, my wife and my children.   
 
 
 
 
 
 
 
 
 
 
 
 
iii 
 
ACKNOWLEDGEMENTS 
First of all, I am great full of ALLAH, who always gave me hope when I am 
disappointed and show the light when I am in the dark. I am thankful to many 
individuals for bringing out this piece of work. I would be akin to express my 
gratitude to my supervisor Associate Professor Dr. Syed Azhar Bin Syed Sulaiman 
for his supervision, advice and essential throughout my research.   
I would like to thank my field supervisors Dr. Lau Kim Kah and Dr. Prem Kumar 
Chandrasekaran for their help and recommendations, the doctors, staff and 
directories in Penang General Hospital and Penang Adventist Hospital for their 
facilitation and cooperation.  
My appreciation to All eight Co. Malaysia, for their support in achieve this research 
by lending the bone measurement instrument. 
Special thanks to Dr. Siti Ruhana Abdulhadi for her helping in patients interviewing, 
and Mr.Ahmed Awaisu for his help in statistical information. 
 My sincere love and thank to my parents who always pray for my success, My wife 
and children who coloring my life, best wishes to my friends Mr. Harith, Mr. 
Muhannad, Miss Hafsa and Mr. Taher for their support and encouragement. 
  
 
Jaafer Mosadek Kurmanji     
 
 
iv 
 
TABLE OF CONTENTS 
ACKNOWLEDGEMENT…………………………………………………………...iii 
TABLE OF CONTENTS…………………………………………………………….iv 
LIST OF TABLES…………………………………………………………………viii 
LIST OF FIGURES…………………………………………………………………..x 
LIST OF ACRONYMS……………………………………………………………..xi 
APPENDICES……...………………………………………………………………xiii 
CONFERENCE PRESENTATIONS………………………………………….…...xiii 
ABSTRAK………………………………………………………………….………xiv 
ABSTRACT..………………………………………………………………………xvi 
 
 
TABLE OF CONTENT: 
1.0 CHAPTER ONE: INTRODUCTION………………………………………….1 
   1.1.0 Background…………………………………………………………………..1 
      1.1.1 Osteoporosis………………………………………………………………..1 
      1.1.2 Bone Mineral Density Measurement……………………………………….4 
      1.1.3 Bone physiology……………………………………………………………6 
      1.1.4 Osteoporosis pathophysiology and risk factors…………………………...11 
v 
 
      1.1.5 Depression…………………………………………………………………18 
      1.1.6 Pathophysiological effect of depression on bone…………………………19 
   1.2 Literatures review……………………………………………………………..22 
   1.3 Problem statement and motivation……………………………………………28 
   1.4 Objectives……………………………………………………………………..30 
2.0 CHAPTER TWO: MATERIALS AND METHOD ……………………….31 
   2.1 Research design……………………………………………………………….31 
   2.2 Research setting ..…..………………………………………………………...31 
   2.3 Study population………………………………………………………………31 
   2.4 Outcomes measurements.……………………………………………………..32 
   2.5 Study approval………………………………………………………………...33 
   2.6 Data collection form…………………………………………………………..33 
   2.7 Patients information sheet……………………………………………………33 
   2.8 Informed consent form……………………………………………………….33 
   2.9 Data Collection procedure…………………………………………….………34 
   2.10.0 Data analysis procedure……………………………………………………36 
      2.10.1 Data entry………………………………………………………………...36 
      2.10.2 Statistical analysis………………………………………………………..36 
 
vi 
 
3.0 CHAPTER THREE: RESULTS……………………………………………...37 
   3.1.0 Data description……………………………………………………………..38 
      3.1.1 Characteristics of the study respondents demographic data………………38 
      3.1.2 Life style among the respondents…............................................................41  
      3.1.3 Data description upon medical conditions analysis in depressed patients...45 
   3.2.0 Bone Mineral Density assessments………………………………………….47 
      3.2.1 Bone Mineral Density assessment according to depression exposure…….47 
      3.2.2 Bone Mineral Density assessment according to demographic……………51 
      3.2.3 Bone Mineral Density assessments according to life style…………..……58 
      3.2.4 Assessing the relationship between risk factors and BMD………………..60 
      3.2.5 Bone Mineral Density assessment according to medical records of  
               depressed patients…………………………………………………………63 
4.0 CHAPTER FOUR: DISCUSSION……………………………………………65 
   4.1 Introduction……………………………………………………………………65 
   4.2 Demographic distribution……………………………………………………..67 
   4.3 Life style distribution………………………………………………………….71 
  4.4 Medical conditions of the depressed patients………………………………….74 
  4.5 Prevalence of low Bone Mineral Density……………………………………...75 
  4.6 Bone Mineral Density comparison…………………………………………….78 
vii 
 
  4.7 Study conclusion ………………………………………………………………91 
  4.8 Study limitations ……………………………………………………………..93 
  4.9 Study recommendations ……………………...………………………………94 
REFERENCES……………………………………………………………………95 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
viii 
 
LIST OF TABLES 
Table                           Title                                                                             Page No. 
1.1              Osteoporosis risk factors………………………………………………………..12                                         
1.2              Cross-sectional studies assessed the relationship of depression with BMD……23 
1.3              Case- control studies assessed the relationship of depression with BMD……...24 
1.4              Longitudinal studies assessed the relationship of depression with BMD………25 
1.5              Studies assessed the relationship of BMD and Antidepressant medications…...26    
3.1              Demographic distributions with depression….………………………………...39 
3.2              Mean Age in depressed and control groups……………………………………40 
3.3              Body Mass Index in depressed and control groups…….……………………….40 
3.4              Life styles of the respondents…………………………………………………..42 
3.5              Medical history of the respondents……………………………………………..43 
3.6             Menopause and pregnancy among female respondents……………...………….44 
3.7             Frequency of signs and symptoms suffered by the depressed patients………….45 
3.8            Duration of depression in depressed patients.........................................................45 
3.9            Medications used by the depressed patients …………………………………….46 
3.10           Low BMD in depressed and control groups……………………………………..48 
3.11           Means of T-scores and Z-scores of depressed and control groups...…….…...….49 
3.12           Means of T-scores and Z-scores of depressed and control males…….….……...49 
3.13           Means of T-scores and Z-scores of depressed and control female………...…….50 
3.14           Mean T-scores between races …….……………………………………….…….51 
3.15           Mean Z-scores between races ……………..…………………………………….51 
3.16           Mean T-score and Z-scores of depressed and control among Malay  
                  respondents………………………………………………………………………52 
3.17           Mean T-score and Z-score of depressed and control among Chinese  
                  respondents…………………………………………………..………………….52 
3.18          Mean T-score and Z-score of depressed and control among Indian  
                 respondents………………………………………………….………………....53 
ix 
 
3.19           Low BMD among respondents based on age………………….…..……………53 
3.20           Means of T-score of depressed patients and controls based on age groups…….54 
3.21           Means of T-score of depressed patients and controls based on age groups among       
                  males only………………………………………………..……………………...54 
3.22           Means of T-score of depressed patients and controls based on age groups among  
                  females only…………….……………………………………………………….55 
3.23          Means of Z-score of employment groups..............................................................55 
3.24           Means of Z-scores of married or single subjects……...…………………………56 
3.25           Means of Z-score among religion groups ……………….….…………….……..56 
3.26          Means of Z-score of education levels groups........................................................56 
3.27           Means of Z-scores based on family history information……...............................57 
3.28           Means of Z-scores based on back pain…………………………………………..57 
3.29           Means of Z-scores based on gender and the presence of depression……………57 
3.30           Means of Z-scores based on Multivitamins intake…..…………………………..58 
3.31           Means of Z-scores based on Calcium supplement intake…..…...........................58 
3.32           Mean Z-score based on the smoking habit…..…………………………………..59 
3.33           Mean Z-score based on the regular exercise habit…..…………………………..59 
3.34           Mean Z-score based on the alcohol consumption….....…………………………60 
3.35          Correlation of smoking with bone mineral density………………………………60 
3.36          Correlation of alcohol intake with bone mineral density………………………...61 
3.37          Correlation of exercise with bone mineral density……………………………….61        
3.38          Correlation of dairy intake with bone mineral density…………………………...61 
3.39           Correlation of exercise with bone mineral density………………………………62 
3.40           Correlation of number of pregnancy with bone mineral density………………...62 
3.41           Correlation of number of abortion with bone mineral density………………......62 
3.42           Linear regression analysis of exercise times and T-score……………………….63 
3.43           Linear regression analysis of exercise times and Z-score……………………….63 
3.44          Correlation of symptoms number with bone mineral density…………………....63 
3.45          Correlation of depression duration with bone mineral density…………………..63 
x 
 
 LIST OF FIGURES 
Figure                             Title                                                                                      Page No. 
 
2.1                            Data collection among control group ………………………………34 
2.2                            Data collection among depressed group…………………………….35 
 
 
 
 
 
 
  
 
      
 
 
 
       
 
 
 
 
  
xi 
 
ABBREVIATIONS 
BMD                         Bone Mineral Density 
BMI                           Body Mass Index   
BUA                          Broadband Ultrasound Attenuation  
dB                              Decibels  
DEXA or DXA         Dual Energy X-ray Absorptiometry 
DSM-III                    Diagnostic and Statistical Manual of mental disorder 3
rd
 edition 
DSM-IV                    Diagnostic and Statistical Manual of mental disorder 4
th
 edition 
HPA                          Hypothalamus-Pituitary-Adrenal 
GDS                          Geriatric Depression Scale 
GHQ                         General Health Questionnaire   
IGF-1                        Insulin Like Growth Factor-1 
IL                              Interleukin  
M-CSF                      Macrophage-Colony Stimulating Factor   
MDD                         Major Depressive Disorder 
NHANES III             Third National Health and Nutrition Examination Survey 
OPG                          Osteoprotegerin  
pDEXA                     Peripheral Dual Energy X-ray Absorptiometry 
PTH                           Parathyroid Hormone     
QCT                          Quantitative Computed Tomography 
QUS                          Quantitative Ultrasound 
RA                             Radiographic Absorptiometry 
RANK                       Receptor Activator of Nuclear Factor- kß 
RANKL                     Receptor Activator of Nuclear Factor- kß Ligand 
RR                              Relative Risk 
SE-QCT                     Single-Energy Quantitative Computerized Tomography     
SOS                            Speed of Sound 
SSRI                           Selective Serotonin Re-uptake Inhibitor 
TCA                            Tricyclic Antidepressant      
xii 
 
TGF- ß                        Transforming Growth Factor- ß 
TNF- α                        Tumor Necrosis Factor- α 
WHO                           World Health Organization 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
xiii 
 
APPENDICES  
Appendix A      Patient information sheet               
Appendix B      Informed consent form 
Appendix C      Data collection form 
Appendix D      Request letter for permission to conduct research at Penang General Hospital   
Appendix E      Request letter for permission to Psychiatric clinic in Penang General Hospital           
Appendix F      Approval from NIH       
Appendix G     Approval from MREC 
Appendix H     Request letter for permission to Penang Adventist Hospital 
Appendix I       Letter of appoint Dr. Lau Kim Kah as a field supervisor 
Appendix J       Letter of appoint Dr. Prem Kumar as a field supervisor 
Appendix K     Permission from Penang Adventist Hospital 
Appendix L      Ultrasound Bone Densitometer CM200 
Appendix M      Simplified operator’s manual 
Appendix N     Pre viva presentation certificate    
Appendix O      Confirmation of thesis edition 
 
CONFERENCE PRESENTATIONS  
Abstract 1            Low bone mineral density of the calcaneus bone in men with    
depressive illnesses. (Poster in 4
th
 AASP-MPS Pharmacy Scientific   
Conference, Penang, Malaysia)  
Abstract 2            Association of depressive illness with low bone density in  
                             Malaysian population. (Oral in 9
th
 ACCP, Seoul, Korea) 
Abstract 3            Evaluation of the morbidity of depression in lowering bone density  
                            between sexes. (Poster in 9
th
 ACCP, Seoul, Korea)  
  
 
 
 
 
xiv 
 
PENILAIAN KETUMPATAN MINERAL TULANG DALAM KALANGAN 
PESAKIT DEPRESI DI PULAU PINANG, MALAYSIA 
ABSTRAK 
Pengenalan: Depresi merupakan penyakit mental yang digambarkan melalui kesedihan, 
hilang minat, tidur dan selera makan yang terganggu serta tahap tenaga yang rendah. Ia juga 
berhubung kait dengan beberapa perubahan paras hormon endogen serta tingkah laku sosial 
yang  teruk yang mengakibatkan perubahan dalam metabolisme tulang dan proses 
pembentukan semula tulang. Kajian membuktikan bahawa wujud hubungan ketara antara 
depresi dengan ketumpatan mineral tulang (BMD) yang rendah dan ini menggalakkan lagi 
usaha untuk menilai perkaitan di atas dalam konteks penduduk Malaysia melalui dalam 
Pulau Pinang, Malaysia. Metodologi:  Kajian ini menggunakan sampel kohort 420 peserta - 
140 daripadanya mempunyai rekod penyakit depresi yang diperolehi daripada klinik psikiatri 
Hospital Besar Pulau Pinang dan Hospital Adventist Pulau Pinang, manakala 280 lagi ialah 
kumpulan bukan depresi iaitu sebagai kelompok kawalan yang terdiri daripada komuniti 
dengan julat umur antara 25-70 tahun. BMD dinilai pada kalsanus tumit dengan mengukur 
T-skor dan Z-skor derivatif ultrabunyi kuantitatif menggunakan densitometri tulang 
Ultrabunyi Furuno CM200 bagi kesemua sampel. Keputusan: Peratusan peserta yang 
mempunyai BMD yang rendah seperti yang dijelaskan oleh T-skor derivatif ultrabunyi 
kuantitatif (< -1) adalah lebih tinggi pada pesakit depresi (P < 0.001) dengan risiko relatif 
sebanyak 1.72 (95% CI 1.40-2.11). dan signifikan dalam kumpulan hanya laki-laki dengan 
risiko relatif 3,0 kali ganda (95% CI 1,99-4,68) dan kumpulan-satunya perempuan dengan 
risiko relatif 1,37 kali ganda (95% CI 1,08-1,74) pada wanita. Setelah menyesuaikan variable 
pengganggu dengan menggunakan regresi logistik biner, dijumpai persatuan BMD rendah 
dengan kemelesetan dalam kumpulan kedua-dua jenis kelamin pada nisbah ganjil 2,76 (95% 
CI 1,61-4,73) dan P-nilai (<0,001) dan menunjukkan hubungan yang signifikan dengan 
kemurungan BMD rendah pada kumpulan laki-laki hanya dengan P-nilai (<0,001) dan aneh 
juadah 19,82 (95% CI 5,64-69,63). Min T-skor derivatif ultrabunyi pada pesakit depresi 
ternyata lebih rendah berbanding kumpulan kawalan bagi kedua-dua jantina sementara 
min Z-skor derivatif ultrabunyi kuantitatif  adalah lebih rendah pada kumpulan depresi 
berbanding kumpulan sihat dalam kalangan lelaki.  Ujian ANOVA tidak menunjukkan 
sebarang pengaruh ketara bangsa, pekerjaan, tahap pendidikan, agama dan gaya hidup yang 
lain terhadap BMD. subjek yang mempunyai amalan senaman yang teratur mempunyai  min 
Z-skor lebih tinggi berbanding kumpulan yang tidak bersenam iaitu P-nilai (0.020) serta 
perkaitan yang ketara dengan tempoh masa bersenam per minggu dengan P-nilai (0.002). 
Ujian Spearman mendapati tiada perkaitan antara Z-skor dengan jumlah simptom yang 
dihidap oleh pesakit depresi P-nilai (0.036). Tidak ada perkaitan antara Z-skor dengan 
xv 
 
tempoh depresi pada pesakit yang menghidapnya. Ujian ANOVA tidak menunjukkan 
perbezaan ketara dalam  min Z-skor pada pesakit depresi yang menggunakan ubat 
antidepresan yang berbeza. Kesimpulan: Depresi mungkin boleh dikaitkan dengan BMD 
yang rendah seperti yang ditunjukkan oleh T-skor derivatif ultrabunyi kuantitatif (<-1) bagi 
populasi Malaysia. Kajian ini membuktikan bahawa lelaki lebih cenderung dipengaruhi oleh 
depresi berbanding wanita dari segi kereputan  tulang. Kajian ini menilai bukti pengaruh 
perlindungan ke  atas BMD. Ia negatif menunjukkan perhubungan ketara antara jumlah 
simptom dengan kereputan tulang. Penelitian ini melaporkan tidak ada keuntungan dari 
penggunaan ubat antidepresan atas lain terhadap BMD ini. menyarankan perhatian 
selanjutnya daripada pakar psikiatri berhubung dengan osteoporosis atau ketumpatan mineral 
tulang yang rendah semasa menangani pesakit-pesakit depresi.  
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EVALUATION OF BONE MINERAL DENSITY AMONG PATIENTS WITH 
DEPRESSION IN PENANG ISLAND, MALAYSIA 
ABSTRACT 
Introduction: Depression a mental illness described by sadness, loss of interest, troubled 
sleep and appetite and low energy levels. It is also correlating with some alterations in 
endogenous hormonal levels as well as poor socio-behaviors, resulting in modification in a 
bone metabolism and bone remodeling process. Studies have shown that there is a significant 
association between depression and low Bone Mineral Density (BMD) and this prompt the 
effort to evaluate this relationship in a Malaysian population in Penang, Malaysia. 
Methodology: The study employed a cohort sample of four hundred and twenty participants, 
140 had depressive illnesses obtained from psychiatric clinics in Penang General Hospital 
and Penang Adventist Hospital, and 280 were non-depressed subjects as controls from the 
community, with their age ranged from 25-70 years old. BMD assessed at the heel’s 
calcaneus by measure the quantitative ultrasound derivatives T-and Z-scores using Furuno 
Ultrasound bone densitometry CM200 for the whole sample. Result: The percentage of 
participant who had low BMD as defined by quantitative ultrasound derivatives T-scores (< -
1) was significantly higher in patients with depressive illnesses (P < 0.001) with relative risk 
of 1.72 (95% CI 1.40-2.11), and significant in male only group with relative risk 3.0 folds 
(95% CI 1.99 to 4.68) and female only group with relative risk 1.37 fold (95% CI 1.08 to 
1.74) in females. After adjusting the confounding variables by applying binary logistic 
regression, found association of low BMD with depression in group of both sexes at odd 
ratio 2.76 (95% CI 1.61-4.73) and P-value (<0.001) and showed significant association of 
depression with low BMD in males group only with P-value (<0.001) and odd ration 19.82 
(95% CI 5.64-69.63). The mean ultrasound derivatives T-score in the depressed patients was 
significantly lower than in control group in both sexes while the mean quantitative 
ultrasound derivatives Z-score was significantly lower in depressed group than in healthy 
group among males only. ANOVA test showed no significant effect of race, employment, 
education level, religion and other life styles on the BMD. Subjects had regular exercise 
habit showed had significantly high mean Z-score comparing to those who had not with P-
value (0.020). This study showed significant correlation of BMD in term of T- and Z-scores 
with the times of exercise doing per week with P-value (0.002). Spearman test significant 
negative correlation of Z-score with the number of symptoms suffered by the depressed 
patients P-value (0.036). No correlation recorded between Z-score and the duration of 
depression in the depressed patients. ANOVA showed no significant difference in the mean 
Z-score between the depressed patients using different antidepressant medications. 
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Conclusion: Depression may be associated with low BMD represented by quantitative 
ultrasound derivatives T-score (<-1) in a Malaysian population. This study concluded that 
males are highly affected by depression than females regarding bone loss. The study 
estimated the evidence of protective effect of exercise on the BMD. It showed a significant 
relationship of the number of symptoms with bone loss. This study reported no advantage of 
use antidepressant medication over the other toward the BMD. The study recommends 
further attention from the psychiatrist with regard to the incidence of osteoporosis or low 
bone mineral density when dealing with their depressed patients.  
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CHAPTER ONE 
1.0 INTRODUCTION 
1.1.0 Background 
Bone fracture has been included along with other most essential health problems, 
especially hip or spine fracture, which costs the government and health organizations 
many of the human and financial resources. Bone fracture occurs due to some types 
of trauma to the bone as a consequence of fall, physical abuse, and vehicle accidents, 
or it might be due to diseases such as osteoporosis that weakens the bone and 
increases its fragility (Becker, 2006).  
Osteoporosis occurs due to several reasons, which are either physiological changes 
happened normally during growing up age or pathological effect of some diseases. 
Some reasons related to pharmacological adverse effects of some medications. 
Several diseases approve to have negative effect on the bone such as 
hyperparathyroidism while others still have unrecognized risk effect on the bone 
such as depression and that what this study tries to investigate. 
 
1.1.1 Osteoporosis 
The World Health Organization (WHO) defines osteoporosis as " a disease 
characterized by low bone mass and micro architectural deterioration of bone tissue, 
leading to ameliorate bone fragility and a consequent increase in fracture risk‖ 
(WHO, 1994). 
Osteoporosis is known as a "silent disease" where the bone loss occurs with no 
symptoms. Lots of people may not be aware that they have osteoporosis until their 
skeletons become too fragile that any unexpected trauma or fall will cause a 
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vertebrae collapse, hip or wrist fracture. Distorted vertebrae may firstly be felt or 
observed in the form of loss of height, severe back pain, or spinal deformities such as 
kyphosis (severe stooped posture) (NRC, 2007).  
It is a case in which the bone loses its proper level of mineral density and increases 
its porosity, which has a negative effect on the skeleton which elevates the possibility 
of bone fractures, leading to an elevation in morbidity, mortality and a decrease in 
quality of life (Lau, 2001). 
According to a study by C. Cooper in 1999 with regard to worldwide prevalence of 
osteoporosis among 200 millions people, the prevalence is directly related to elderly 
population. In other words, human age has a clear intensive effect on bone tissue 
structure and its mineral contents where the ageing factor is enormously responsible 
for the incidence of osteoporosis (C.Cooper, 1999, Reginster and Burlet, 2006).  
The prevalence of these osteoporotic fractures increases with time where the total 
number of hip fractures in both genders in 1990 was reported to be 1.26 million 
(Johnell and Kanis, 2006, Gullberg et al., 1997). Accordingly, in 2000, the annual 
worldwide fracture due to osteoporosis was more than 8.9 million cases, in which 
more than 4.5 million cases occurred in Europe and America. An estimated number 
of fractures due to osteoporosis, both in men and women within 50 years old and 
above, is shown by regional study by WHO. The highest number of fracture is in 
Europe with an estimation of 3.1 million cases. South East Asia is considered the 
third of the regional survey with 1.55 million cases estimated while Africa is 
considered to have a lower level with the estimation of 0.075 million cases (WHO, 
2004, Johnell and Kanis, 2006). 
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Osteoporosis is not a rare disease in Malaysia. The prevalence of osteoporosis in 
Malaysia in 2005 was reported at 24.1%, usually affecting the hip (Loh and Shong, 
2007).  
Osteoporotic hip or vertebral fractures have cost health institutions a lot of expenses 
during hospitalization, where direct costs of fractures due to osteoporosis for health 
care and hospital services in the year 2000 in European Union were estimated at RM 
133 billion (Kanis and Johnell, 2005). In USA, 63 billion RM has been spent for the 
cost of osteoporotic fractures estimated in 2005, which is predicted to rise to 
approximately 84 billion RM within 2025 as a consequence of this increase parallel 
with the time of the prevalence of those osteoporotic fractures (NOF, 2008). In 
Malaysia, direct hospitalization cost for hip fractures in 1997, according to 
Malaysian Guidelines on Management of Osteoporosis, was estimated at RM22 
million (Khir and Lee, 2007). 
Osteoporosis is classified into two main classifications; primary osteoporosis and 
secondary osteoporosis. Primary osteoporosis is sub-classified into two types; Type I 
i.e. postmenopausal osteoporosis which relates to women after their menopause. 
Wrist fractures and vertebral crush fractures are usually associated with Type I 
osteoporosis. The second sub-classification of primary osteoporosis is Type II i.e. 
age-related or senile osteoporosis, which impinges on men and women of older age 
than 70 and is usually associated with hip breaks and vertebral wedge fractures 
(Riggs, 1991). Secondary osteoporosis occurs due to the effect of diseases such as 
hyperparathyroidism and type 2 diabetic mellitus or due to medication such as 
glucocorticoids, chemotherapy and insulin. 
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1.1.2 Bone mineral density measurement 
The bone mineral density is estimated by the amount of bone mineral content in unit 
(gram) in the surface area in a square centimeter (cm
2
) to be (g/cm
2
). In evaluating 
bone density, a standard deviation called T-scores indicates that the amount of one's 
bone mineral density varies from the mean. It is scaled from positive scores, which 
indicate good bone density and is reduced to negative scores, which indicate low 
bone density. WHO puts a criteria in the diagnosis of normal bone density, 
osteopenia and osteoporosis i.e. the T-scores > -1 means normal bone density, while 
osteopenia is estimated when the T-scores is within -1 to -2.5, and if it is less than  
-2.5, then this indicates the osteoporosis.  
In addition to the T-scores, there are Z-scores, which are the value of standard 
deviations in patients where their bone density differs from the normal BMD 
according to the age, sex, and race of these patients. Z-scores are used in 
premenopausal women and men under the age of 50 as well as in children. 
The bone density is measured by different manners, which include Dual Energy X-
ray Absorptiometry (DEXA or DXA), spinal Quantitative Computed Tomography 
(QCT), Peripheral Dual Energy X-ray Absorptiometry (pDEXA), Quantitative 
Ultrasound (QUS) and Radiographic Absorptiometry (RA). In comparing these 
techniques, the RA is considered to be the earliest way in measuring bone density, 
which has many limitations like high expense, time-consuming measurement and 
radiation in addition to the low accuracy. DEXA is a highly accurate absorptiometry 
technique of time-saving measurement, which undertakes the measurement in central 
axial, hip and other peripheral skeletons. DEXA is usually used in the diagnosis of 
osteoporosis and to approve the effect of new drug therapy.  pDEXA is similar to 
DEXA in these advantages, but it is used only to measure bone density in peripheral 
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axis. The disadvantage of DEXA and pDEXA is the high cost and the radiation. For 
QCT, it has high expanse as well as high radiation. However, it is different from 
DEXA in that it estimates BMD in accurate parameter of cubic centimeters (cm
3
) 
which is a volumetric parameter while DEXA estimates in unit area square 
centimeter (cm
2
) and has an ability to differentiate between cortical and trabecular 
bones.  
While osteoporosis is a systemic disease, bone density loss occurs in the whole 
skeleton but not at the same rate, that a study estimated one-half of those who 
experienced a significant decrease in spine BMD at 5 years showed no significant 
fall in forearm. It showed a significant contract for total hip with spine and whole 
body BMD than for the femoral neck concluding that changes at the commonly 
measured sites are discordant (Abrahamsen et al., 2001).  
Most QUS measure bone density on heel, forearm and fingers where this technique 
has its own advantages i.e. no radiation is included in this process while the machine 
is small, lightweight and portable in addition to the short time quantify the duration. 
However, the restriction of this type of measurement is that it is not highly accurate 
in comparison to DEXA or QCT. 
Mostly, types of QUS determine the T-scores and Z-scores in calcaneus bone, which 
consists of 95% of trabecular bone, which is similar to the type of the bone in spin 
and hip, and it is located between relatively flat faces. This type of bone causes 
scatting of the sound wave. The idea of ultrasound absorptiometry is by measuring 
broadband ultrasound attenuation (BUA) in a unit decibel (dB) which is decreased in 
high porous bone tissue. Another technique of QUS is to measure the speed of the 
sound (SOS) which travels through the calcaneus tissue where this speed reduces in 
low bone density. The QUS is usually used in most studies as well as in the screening 
  
6 
 
of bone density and osteoporosis (Blake and Fogelman, 2002, Faulkner, 2001, 
Miller, 2002, Mautalen and Oliveri, 1999, Sterkel and Miller, 2000). 
 
1.1.3 Bone physiology 
In order to understand physiology and pathophysiology of osteoporosis and bone 
fractures as the outcome of osteoporosis and how and why they occur in most   
people‘s life, first bone structure and matrix of the bone tissue in the human body 
must be defined as well as get a review on the included components in the bone 
tissue, bone metabolic processes such as bone resorption and reformation activities 
and biochemical compounds that manage these activities. 
Bone is a live connective tissue, which has growing ability where the skeletons are 
composed of cavity bones in which a solid cortical shell covers a marrow space 
containing variety amounts of trabecular bone. The vertebrae, pelvis, skull, and 
scapulae are filled with continuous trabecular network while in long bones, the 
trabecular bone is found only at the end of these bones. In other parts of the long 
bone, there is cortical bone, which concentrates on the areas under compression or 
subject to impact loading, where the long bones have a function as major weight 
bearing bone, carrying on large bending and torsion forces produced during the 
movement while the trabecular bone sustains lauding of the axial compression. 
(Bono and Einhorn, 2003, NRC, 2005).  
Chemically, bone is a complex structure which consists of collagen protein matrix, 
upon which the crystals of calcium and phosphate are lain down in a prepared way. 
In addition to collagen and minerals, a large number of non-collagen proteins are 
present in the skeleton. These proteins play a role in signaling between cells and 
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matrix as well as to regulate the distribution of minerals on the collagen scaffold 
(Raisz et al., 2005). 
In addition to the supporting function of the bone and the protection of vital organs, 
it has a protected chamber of blood formation marrow and serves as a store for 
mineral ions (Ca
+2
, PO4
−3
, Mg
+2
). Bone has a rule in protecting the body from 
acidosis, i.e. it can adsorb heavy metals and toxins, which lead to a decrease in their 
harmful effect on other body tissues (Turner, 1998).  
Since the skeleton is a basic organ that supports standing and mobility of the human 
body, it must have two properties; first, it must have proper rigidity that improves 
supporting function of bone, which is obtained through the way of arrangement of 
minerals in bone structure, and second, it must have suitable flexibility that protects 
itself from being broken by any trauma and this is obtained by collagen, which is 
responsible for tensile strength. Therefore, to preserve these two properties and 
maximize bone protection, the bone is exposed to an essential process called bone 
remodeling process (Boskey et al., 2006). Remodeling is a local removing process of 
the aged bone by replacing it with newly formed bone. On the other hand, the 
resorption activity will release calcium for physiological requirements and improve 
the bone structure in order to make it better for its physical role while the formation 
activity is to restore the bone which is lost (Martin et al., 2001).  
Bone remodeling is undertaken by two types of bone cells: 
(a) Osteoblast cells which are responsible for forming the bone matrix in which they 
are usually called bone-forming cells. 
(b) Osteoclast cells which are responsible for resorbing and degrading the existing 
bone. Even the osteoblast cells and mast cells in bone marrow are responsible for 
stimulating the differentiation and activating osteoclast cells.  
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There are another type of bone cell which do not have any role in bone remodeling 
process called osteocytes which are mature osteoblast cells surrounded by bone 
matrix.  
The first "activation" stage starts with osteoclast cells which attach to the mineralized 
bone surface and begin the resorption by releasing hydrogen ions and lysosomal 
enzymes, mainly cathepsin K, which has the ability in acidic environment, to 
dissolve all bone matrices compounds as well as collagen protein. This resorption 
activity of the osteoclast cells forms irregular cavities in the cortical bone called 
Cylindrical Haversian Canals as well as on the trabecular bone surface called 
Howship lacunae. Directly, after the osteoclast completes the bone removal, the 
second "reversal" stage starts where in this phase, the mononuclear cells are lined on 
the bone surface. They dissolve collagen and deposit of proteoglycans to form a cell 
layer called cement line, followed by the release of a growth enzyme to start a 
"formation" phase. During the third ―formation‖ stage, a final phase of the 
remodeling sequence, the cavities created by resorption activity, can be completely 
filled in by the prepared layers of osteoblast cells and release a mineralizable matrix. 
Once the osteoblasts have completed their work of matrix synthesis, they can become 
flattened lining cells on the bone surface and be hidden in the bone as an osteocyte. 
The osteocyte cells are vital cells for regulating fluid flow through the bone and the 
variations in this fluid flow may provide a signal for cellular feedback to mechanical 
forces such as impact loading (Raisz, 1999, Eriksen, 1986). 
There are endogenous factors and biological mediators, which have massive effects 
on this mentioned process such as parathyroid hormones, vitamin D, estrogen, leptin 
and cytokines (Khovidhunkit et al., 1997, Bilezikian et al., 2001, Hodsman et al., 
2002). Any changes in the levels of these mediators lead to the modification of this 
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remodeling process maintenance, causing changes in regular levels of mineral ions in 
the bone which vary the required bone properties where this mostly decreases bone 
mineral density and increases the incidence of osteoporosis.  
 Most of the systemic calcium regulation mediators are parathyroid hormone (PTH) 
which is responsible for regulating serum calcium level by resorbing calcium from 
bone. It is a strong stimulator of bone resorption. In spite of PTH considered as an 
anabolic factor, PTH at high serum concentration causes acute inhibition of collagen 
synthesis but prolonged irregular administration of this hormone leads to the increase 
in bone formation.  
In general, the parathyroid hormone stimulates bone resorption and formation but 
due to the slow bone formation process, it leads to the degradation in bone density. 
Ageing is one of the elevating factors of serum PTH where this may increase bone 
resorption which mostly occurs in cortical bone (Dempster et al., 1993) 
Calcitriol 1,25-dehydroxy-vitamin-D, the second calcium regulating hormone, is a 
metabolite of vitamin D which is synthesized from cholesterol found in the skin by 
the action of ultraviolet sun light. The metabolism process occurs in the liver and 
kidney to form active hormone of 1,25-dehydroxy-vitamin-D. This active hormone is 
responsible for absorbing calcium and phosphorus from intestine as well as 
stimulating bone resorption as a protection mechanism to provide calcium and 
phosphorus from the skeleton in case of deficiency of these two minerals in the 
intestine. The elevation in serum calcitriol level increases feedback in PTH in which 
it has resorption effect on the bone (Christakos et al., 2006). 
The third major calcium maintaining hormone is calcitonin. It is secreted from C-
cells in thyroid gland as a response to the elevation in a serum calcium level where 
this calcitonin inhibits resorption activity of osteoclast cells (Ikegame et al., 2004).  
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There is general growth-regulating hormone effect on the bone remodeling process, 
for instance, growth hormone, insulin like growth factor (IGF-1), thyroid hormone, 
sex hormone and glucocorticoids in addition to leptin hormone.  
Insulin-like growth factor has constructive effect on the bone by improving the bone 
formation process (Hayden et al., 1995) while thyroid hormone stimulates both 
osteoclast and osteoblast cells which, in conclusion, raise in bone turnover and 
increase the bone resorption (Duncan Bassett and Williams, 2003). 
Estrogen and testosterone hormones are also considered among the most important 
hormones which affect bone remodeling process. These two hormones diminish 
remodeling of the bone and play a role in reducing bone resorption. Estrogen inhibits 
bone resorption by decreasing the production of osteoclast cells and enhancing 
osteoblast cells to express more osteoprotegerin (OPG), a local mediator which 
prevents the activation of osteoclast cells (Liang et al., 2008). While the androgen 
hormone has less activity in inhibiting the bone resorption, it has essential effect for 
stimulating bone formation and indirectly protects the bone by raising the muscle 
growth which plays a positive role on bone density (Leder et al., 2003). 
In reverse to sex hormones cortisol is the hormone released from adrenal gland. It 
has negative effect on bone where it directly enhances bone resorption through the 
inhibition of osteoblast cells formation and replication and increases the activity of 
osteoclast cells. Besides, it indirectly affects a decrease in IGF-1 level, elevating the 
circulating PTH and reducing the production of sex steroids. Another indirect 
negative effect of cortisol is reducing calcium intestinal absorption (Lane and Lukert, 
1998, Lafage-Proust et al., 2003, Pereira et al., 2001, Hofbauer et al., 1999).  
After exposing osteoblast cells and mast cells in bone marrow to the parathyroid 
hormone, prostaglandin E2 and 1,25-dehydroxy-vitamin-D3 stimulate the release of 
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cytokine called RANKL ( Receptor Activator of Nuclear factor-kß Ligand). This 
protein is generated from preosteoblast and activates stromal cell found in the bone 
marrow. These ligands are bound to the activated receptors called RANK located on 
osteoclast precursors and initiate differentiation of these precursors to mature 
multinuclear functional osteoclast cells which start the bone resorption. The 
interaction of RANKL and RANK is prevented by decoy receptor osteoprotegerin 
(OPG) which has ability to bind with RANKL and inhibits osteoclast activation 
where OPG is considered as anti-resorptive cytokine. Another ligand produced by 
preosteoblast is macrophage-colony stimulating factor (M-CSF) that binds with       
c-fms. A receptor is also found on the precursor of osteoclast which also induces 
osteoclastogenesis (Khosla, 2001). This osteoclastogenesis process is enhanced by 
some local cytokines and prostaglandins such as prostaglandin E2, interleukin-1, 
interleukin-6, tumor necrosis factor-α (TNF- α), in addition to local growth factors 
such as Insulin like Growth Factor-1 and transforming growth factor (TGF-ß) which 
have important additional function for bone remodeling including bone development 
(Roux and Orcel, 2000). 
 
1.1.4 Osteoporosis pathophysiology and risk factors  
In osteoporosis, there is a highly diminish of density and a mineralized matrix of the 
bone which increase the porosity of bone (cylindrical Haversian canals and Howship 
lacunae) and elevate its fragileness. This fragileness is approved through the 
imbalance of remodeling processes when the resorption activity of the osteoclast 
exceeds the reforming activity of the osteoblast within two ways, either by excessive 
bone resorption or defect, in reforming the damaged and resorbed bone influenced by 
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biological factors which rule osteoclast number and activity of these mediators 
systemic or local (Raisz and Rodan, 2003).  
 
 
The most common osteoporosis related risk factors are listed in Table 1.1: 
Table 1.1 Osteoporosis risk factors. 
1. ageing 
2. gender 
3. race 
4. Body Mass Index (BMI) 
5. smoking 
6. alcohol consumption 
7. exercise 
8. food intake 
9. family history 
 
Ageing is considered as one of the most essential causative factors in osteoporosis 
incidence. Bone mass modifies over the life of human being. Bone mass raises fast 
from puberty period until mid 20s to mid 30s when the peak of bone mass is 
achieved. Then, the bone loss starts at 1% rate of bone per annum (Kenny and 
Prestwood, 2000, Reginster and Burlet, 2006). 
Osteoporosis is influenced by many factors which relate directly or inversely to the 
incidence of this disease. Individual ageing is first and important factor which affects 
the bones through different manners in which elder individuals are estimated at 20%-
30% of malnutrition. This malnutrition decreases the required protein-calories intake. 
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Protein is one of the competent of bone tissue in addition to the calories required in 
the process of bone formation. On the other hand, deficiency of protein-calories 
intake reduces the production of IGF-1 where it is produced by osteoblast and is a 
major anabolic factor for bone when the serum and skeletal levels of IGF-1 decline 
with the ageing that may contribute to the pathogenesis of age-related osteoporosis 
(Rizzoli et al., 2001, Rosen et al., 2006). Other associations of ageing on bone 
density are the reduction in calcium intake and deficiency of vitamin D level which 
also reduce the efficient calcium intestinal absorption and lead to secondary 
hyperparathyroidism.  
A rise in PTH is triggered by a fall in serum 25-hydroxy-vitamin-D and low dietary 
calcium intake in elders which can result to enhance the calcium mobilization from 
bone stores and diminish the bone formation and give clarification for bone loss in 
vitamin D insufficient and deficiency of calcium intake (Bouillon et al., 1997).  
Ageing enhances osteoporosis through hormonal changes which occur with ageing. It 
is accompanied with a reduction in the secretion of gonadotropin releasing hormone 
(GnRH), gonadotropin luteinizing hormone (LH), testosterone and somatotropin 
(growth hormone) in human which play important roles in bone formation (Veldhuis, 
2007). 
Second risk factor is gender which has different effects on the incidence of age 
related fractures. In other word, the incidence of fractures in women increases with 
the increase in their ages as compared to men, in addition to high prevalence of 
osteoporosis among women. In women, the elevation of bone fragility usually 
coincides with the beginning of menopause and estrogen deficiency. Bone loss 
relates to the estrogen deficiency, initially takes place in early rate as compared to 
other age-related reasons of bone loss. Therefore, bone loss is hastened in women, 
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leading to earlier expansion of osteoporosis in women‘s life span in addition to the 
incidence of bone fracture as compared to men. As a result, hospitalization cost after 
osteoporotic fractures becomes higher in female than in male. However, the 
morbidity is equal in both sexes while the mortality is high among men after the bone 
fracture (Geusens and Dinant, 2007). 
Third risk factor is race where it differs in terms of its effect on the incidence of 
osteoporosis, depending on sub-factors - cultural, religious, dietary, geographic as 
well as other differences among races which are recognized as ethnicity and 
acculturation. Acculturation is a scale to measure how much an ethnic group 
assimilates the language, habits and cultural values of the country or area to which it 
migrates (Villa et al., 2001). 
Smoking has been proved to have negative effect on bone density There are 
evidences that smoking increases the risk of bone degradation in both men and 
women which increases the possibility of fractures later in their life. A meta-analysis 
study by Law and Hackshaw (1997) including 29 cross-sectional designed studies 
and 19 case-control and cohort studies report significant negative effect of smoking 
on postmenopausal women by accelerating bone loss in an additional 0.2% in each 
year, but not a significant association on premenopausal women. In general, smoking 
increases the possibility of hip fracture cumulatively with age where smokers at the 
age of 60 have possibility of 17% higher which increases with the age reaching 71% 
higher at 80 (Hollenbach et al., 1993, Law and Hackshaw, 1997). The harmful effect 
of smoking - direct or indirect- is similar to the nicotine compromises bone 
reformation and perhaps by motivating ischemia and straight inhibitory effect on 
osteoblastic cells, where smoking reduces calcium absorption, elevates parathyroid 
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hormones serum level (Rapuri et al., 2000) and is approved to increase  circulating 
cortisol levels (Steptoe and Ussher, 2005). 
Besides, alcohol intake has been varying the outcome on bone density but the vast 
majority of these outcomes is negative on the bone density and elevates the 
possibility of lower extremity fractures. Low to moderate alcohol consumption per 
week (1–27 drinks for male and 1–13 drinks for female) is not related to the 
incidence of hip fracture. In men, relative risk of hip break is gradually large for 
those who consume 28 drinks or further per week. Bone loss has been revealed to be 
increased in men with alcohol ingestion above the median and the latest conclusions 
record that alcohol abuse may even be correlated with a rise in the relative risk of hip 
fracture while it is announced that women who weekly drink 14-27 times have the 
relative risk of hip breakage depending on age (Malnick et al., 1999). In other meta-
analysis studies, it is found that there is an elevation in the risk of hip fractures 
directly with daily consumption of alcohol starting with low risk of 0.5 drinks per 
day to a higher when it reaches and passes 2 drinks per day (Berg et al., 2008).This 
degradation effect of alcohol on bone occurs due to different manners which may be 
direct or by contribution of other diseases related to bone density in which alcohol 
approves causative factor of liver cirrhosis and chronic liver diseases which are 
associated with low bone mineral density (BMD) (Davies et al., 2005, Uretmen et 
al., 2005). Alcoholism contributes to hypogonadism by affecting reproductive axis 
and elevating cortisol level (Warren and Vu, 2003). Alcohol directly affects the bone 
density by diminishing osteocalcin level which is a vitamin K dependent protein 
synthesized by osteoblast. Serum osteocalcin concentration is raised in states of high 
osteoblastic activity and declined in phases of diminished bone synthesis. 
Furthermore, low serum level of osteocalcin for the period of acute alcohol 
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intoxication and in chronic alcohol consumption may point that alcohol reduces 
osteoblastic activity (Labib et al., 1989). In addition to this harmful effect of alcohol 
on bone, there are several studies supporting a defensive consequence of moderate 
alcohol intake opposing hip fracture to moderate consumption of alcohol and this 
appears to be associated with lower risk of fractures and is statistically not 
significant. They suggest that bone destruction and fracture risk will only be 
significantly on rise in men with alcohol abuse and not in the condition of moderate 
alcohol consumption (Nguyen et al., 1996). 
Other risk factor on bone density which is the most important one is dairy and 
calcium-contained product intake alone and in combination with exercise and 
physical mobility. There are lots of evidences exhibiting the relationship between 
calcium intake and bone density and the role of exercise in decreasing bone porosity. 
A cross-sectional study in Japan includes male and female high school students. The 
BMD of the girls who exercise has improved with an increase in the times of milk 
ingestion to a certain peak but decreases when the milk is taken daily.  Bone density 
of the girls who do not exercise is unaffected by the frequency of milk intake. While 
in the boys, bone density is intensified in both groups who doing exercise and other 
who do not when the milk consumption increases. These outcomes mention that the 
intake of milk is useful to pick up BMD in the high school boys (Yoshiia et al., 
2007).  
A new study provides evidence on positive effects of regular childhood dairy intake 
on adolescent bone density. These useful effects of dairy intake on bone health are 
supported by diets with high meat and other non-dairy proteins which stimulate the 
secretion and action of IGF-1 which plays an important role in  children‘s growing 
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and holds up bone formation and assists in reducing renal losing of calcium which 
may occur as an outcome of protein intake (Moore et al., 2008).  
Women should be educated to change their behaviors towards the ways of preventing 
osteoporosis. This means that when postmenopausal women improve the ageing with 
proper calcium intake and weight-bearing exercise conducts, it may be useful in 
hindering osteoporosis (Rachelle et al., 2008). 
Bone mineral density varies from person to another depending on family history. A 
study conclusion shows that the arrangement of early postmenopausal women with 
family fracture history at any age has occurred in mothers or sisters due to low 
trauma where this is one of the best expectance of low BMD and a fracture in that 
group of women (Grainge et al., 1999). A meta-analysis estimates that the risk of 
fracture is obtained from international cohorts population-based studies which 
conclude that parental history of fracture, especially when we are talking about 
history of hip fractures, confirms an increased risk of fracture which is independent 
of BMD (Kanis et al., 2004).  
As for secondary osteoporosis, it is developed by the effect of either diseases, 
medication, or both of them. Recent studies show that there is unclear as to the risk 
consequence of depression on the bone mineral density and it might be considered as 
an unrecognized risk factor of secondary osteoporosis or low bone density (Cizza et 
al., 2001) and several studies have established an involvement between 
antidepressant drugs usage and osteoporotic fracture (Liu et al., 1999).  
 
 
 
 
  
18 
 
1.1.5 Depression 
WHO defines ‗depression‘ as  ―a common mental disorder, characterized by sadness, 
loss of interest or pleasure, feelings of guilt or low self-worth, disturbed sleep or 
appetite, low energy and poor concentration, affecting about 121 million people 
worldwide" (WHO, 2008). 
In order to achieve good clinical outcome treatment, it is necessary, during 
assessment and monitoring, to consider a wide spectrum of Major depressive 
disorder (MDD) in which  it is composed of a number of emotional, cognitive, 
behavioral and physical symptoms (Truax et al., 2006). 
Today, depression is highly common experienced and diagnosed as mental disorder 
in the United States. It is estimated that 16.9% of the population shows a significant 
life span as well as currently exposure to depressive disorder, where up to 13.2% of 
men and 20.2% of women have an active MDD while higher prevalence is within the 
age range of 30-59 years (NCS, 2007). 
While Australian national survey estimates lower than the USA survey, the total 
frequency rate of Diagnostic and Statistical Manual of mental disorder, 4th edition 
(DSM-IV) proves that the prevalence of MDD is around 3.2% among Australian, 
which highly occurred among women with 3.9% than in men about 2.4% (Wilhelm 
et al., 2003).  
In Malaysia, a study by Ministry of Health and Malaysian Psychiatric Association on   
rural survey reports that depressive disorder is highly frequent psychiatric illness 
identified with prevalence rate of 3.6%. The prevalence is also shown to be highly 
occurrence among people with physical problems and during the postpartum period 
(Majeed and Pereira, 2007). Depression has important risk morbidity effect and it is 
  
19 
 
correlated with the elevation of mortality 2-3 times more particularly in males 
(Zheng et al., 1997). 
 
1.1.6 Pathophysiological effect of depression on bone 
There are many intervening processes that may conduce to the relationship between 
depression and bone mineral density. Two important ways in which depression is 
linked to straight affect BMD and risk of osteoporotic fracture are physiological 
changes (e.g., modification in hormonal system) and the assumption of bad health 
behaviors (e.g., smoking and physical immobility). It is also speculated that 
depression itself is not causally linked to bone strength but is associated with other 
conditions related to co-morbid medical conditions as well as the use of psychiatric 
medication. 
Physiologically, and as mentioned, many endocrine hormones affect bone formation 
and/or bone resorption. Elevated level of hormones, either increases osteoclast (bone 
resorption) activity (e.g. cytokines interleukin-6 (IL-6) and (IL-1), tumor necrosis 
factor-alpha (TNF-α) and PTH) or inhibits osteoblast (bone formation) activity (e.g., 
leptin and cortisol) are envisaged to be correlated with lower BMD. Levels of many 
hormones that organize bone metabolism are altered in depression.  
The elevation of cortisol level is the most common consequence of hypothalamus-
pituitary-adrenal axis (HPA axis) activation during depression and this elevation 
persists for long period even after effective treatment of major depression especially 
among old age where this hypercortisolism has potent effects on bone metabolism 
(Arborelius et al., 1999, Peeters et al., 2004, Burke et al., 2005, Beluche et al., 
2009). Cytokines Levels such as interleukin-6 and other inflammatory markers are 
also increased during depression and this elevated level of pro-inflammatory markers 
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is associated with low BMD (Bob et al., 2009). Depression is associated with 
reduced levels of gonadal hormones estrogen and testosterone (Rajewska and 
Rybakowski, 2003, Rehman and Masson, 2005, McIntyre et al., 2006), which are 
diminished in reproductive hormones, leading to mood disturbance (Rubinow and 
Schmidt, 1996, Carnahan and Perry, 2004). These sex hormones play a regulator role 
in bone formation and remodeling process (Keles et al., 2006, Kung, 2008). 
During depression, there is alteration in biochemical markers of a bone remodeling 
process estimated through several studies. In 2000, Herran and colleagues have 
compared the markers of bone turnover between first-episode subjects of MDD and 
controls which show that the markers of bone turnover such as osteocalcin and 
telopeptide are significantly higher in a patient with depression as compared to 
control, and it estimates a high level of cortisol among depressed patients but there 
are no changes regarding interlukin-6 (Herran et al., 2000).  
In 1996, Michelson and colleagues have estimated high cortisol urinary excretion 
and low serum osteocalcin among women of past and current exposure to depression 
(Michelson et al., 1996).  
Kahl and colleagues in (2005) reported elevated levels of osteocalcin, cortisol and 
interleukin-6 among cases of comorbid MDD and borderline personality disorder in 
comparison with the controls (Kahl et al., 2005). Another study in (2007) by 
Altindag and colleagues estimated higher level of plasma cortisol and lower level of 
osteocalcin among outpatients depression as compared to the controls (Altindag et 
al., 2007). Depression is associated with poor health behaviors which physiologically 
affect BMD. Depression is associated with smoking, alcohol abuse, less physical 
activity and sedentary life style which have negative effect on the bone density. 
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Smoking is reported to elevate depression among patients which is associated with 
lower BMD by inhibiting estrogen activity and calcium absorption by intestines 
(Hagiwara and Tsumura, 1999, Malnick et al., 1999, Almeida and Pfaff, 2005, 
Husky et al., 2008, Kuo et al., 2008). 
Apart from that, depression is reported to have an association with high alcohol 
consumption (Grant and Harford, 1995, Dixit and Crum, 2000). Alcohol dependence 
and heavy alcohol users are also associated with low BMD through the reduction of 
bone cell generation and function (Chakkalakal et al., 2005, Berg et al., 2008). 
Depression is inversely associated with physical inactivity where low physical 
activity is associated with high depression scores and vice versa. Physical activity 
and exercise, especially resistance exercise, play an important role in the 
improvement of the BMD (Harris et al., 2006, Korpelainen et al., 2006, Adami et al., 
2008, Ku et al., 2009). 
Another way to raise the possibility of having low bone mineral density among 
depressed patients is antidepressant medications. Recent studies show that there is a 
relationship between depression and low BMD by the influence of antidepressant 
medication use (Schwan and Hallberg, 2009). 
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1.2.0 Literature review 
There are several studies attempted to investigate the association of major depressive 
disorder with the BMD in different reigns around the world.  
The first study under took the association of depression with BMD was by Schweiger 
and colleagues in 1994 in Germany. They used single-energy quantitative 
computerized tomography (SE-QCT) to measure BMD at lumber spine It was found 
that after age adjusting, the average of BMD values among depressed group was 
15% lower than the non-depressed group (Schweiger et al., 1994b).  
Most of the following studies repeated the initial finding of Schweiger et al.; 
however some studies estimated no significant association between depression and 
the BMD. The researchers conducted this investigation through different manners, 
the difference either in the sampled population, design of study or the utility of BMD 
measurement.  
The majority of the studies undertook women only like a study by Coelho et al. 1999 
and Petronijevic et al. 2008 (Coelho et al., 1999, Petronijevic et al., 2008), while are 
there few studies carried out males only like a study by Wong et al. 2005 (Wong et 
al., 2005).  
Some studies tried to employed cross-sectional design which demonstrated in Table 
1.2 while other studies employed a cases and matched with controls that shown in 
Table 1.3.  
Most of the studies utilized DEXA in detecting BMD; one study only utilized 
quantitative ultrasound densitometer which is conducted by Alice et al. (2008)(Alice 
et al., 2008). Table 1.4 demonstrated the longitudinal studies that relied on a 
prospective follow up for the sample subjects to compare the rate of bone density 
loss between cases and controls. 
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